trending Market Intelligence /marketintelligence/en/news-insights/trending/IuKLaKOXBfJju2yvHPwEDg2 content esgSubNav
In This List

ResMed, BMC, 3B Medical settle global litigation

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


ResMed, BMC, 3B Medical settle global litigation

ResMed Inc., BMC and 3B Medical signed a global settlement of all litigation between the parties, none of which admitted to liability.

As part of the agreement, Beijing-based BMC and Florida-based 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time settlement payment to 3B to close the Florida litigation between the two parties.

The five-year agreement between the three companies resolves all pending litigation before the U.S. International Trade Commission, lawsuits pending in district court in Florida and California, foreign litigation in China and Germany and validity challenges pending in various international patent offices.